Furthermore, miR-29a controls the platelet-derived growth factor (PDGF) pathway and targets TNF receptor-associated factor 4 (TRAF4)/Akt signaling, which inhibits the stemness and tumor formation of glioma cells25. This evidence concerns the gene TRAF4 and neoplasm.